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Summary The prevalence of primary liver cancer (PLC) varies throughout the world. It has been attributed
to variations in incidence of the predominant histological type, hepatocellular carcinoma (HCC). The incidence
of PLC types other than HCC such as cholangiocellular carcinoma (CCC) is far less known, especially in
low-incidence areas. The aetiology of HCC and other PLC types is obscure, with the exception of the
association between HCC and cirrhosis as well as chronic viral hepatitis. The present retrospective incidence
and aetiology study concerns a well-defined population from a period with a high autopsy frequency.
Preserved biopsy specimens were re-evaluated histopathologically and patient records were studied. Among
590 histologically verified cases of PLC, HCC constituted 90%, CCC 8% and a mixed form of these types 1%.
At the end of the study period the annual age-standardised incidence rate of HCC was 3.6 cases per 100 000
inhabitants. Other PLC types were hepatoblastoma (n = 3), fibrolamellar carcinoma (n = 2), angiosarcoma
(n = 1) and infantile haemangioendothelioma (n = 1), each constituting less than I % of the PLC cases.
Comparing HCC with CCC we found that cirrhosis (70%) and alcoholism (21%) was significantly more
frequent in HCC, and cholelithiasis was significantly more common (60%) in patients with CCC. In the
majority of the PLC cases with liver cirrhosis this disorder was unknown before diagnosis of the tumour.
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Primary liver cancer (PLC) is one of the most common
malignancies in the world (Cook, 1985), but the prevalence
varies widely geographically (Vitale et al., 1986; Bassendine,
1987). In Sweden, a low-rate area, PLC accounts for less
than 2% of all diagnosed cancers (Cancer Registry, 1960-82;
Vitale et al., 1986). The great variability of PLC incidence
throughout the world appears to be due to variations of the
predominant histological type, hepatocellular carcinoma
(HCC) (Anthony, 1987). The less common type, cholan-
giocellular carcinoma (CCC), is believed to occur with mostly
the same frequency everywhere except in parts of South-East
Asia, where CCC is reported to be more frequent (Anthony,
1987). Other liver cancer types seem to be very rare
(Anthony, 1987).
There are many reports on the incidence and relative pro-
portion of various liver cancer subtypes; however, the
reported figures may not reflect the true circumstances. Most
of the reports derive from large referral centres without a
defined population, and usually consider highly selected sam-
ples of patients (Polterauer and Ulrich, 1982; Hey and
Rockelein, 1985) or deal with a patient cohort, in which only
a minority of known cases is histologically analysed (Liver
Cancer Study Group of Japan, 1990). Furthermore, since
many cases with PLC may be found incidentally at autopsy
(Hey and Rockelein, 1985; Hafstr6m, 1986) a low autopsy
frequency results in exclusion of a significant number of
patients with clinically unknown PLC.
The prognosis of PLC, with possible exception of
fibrolamellar carcinoma (Anthony, 1987), is usually very
poor (Bengmark et al., 1971; Okuda et al., 1984). Conse-
quently, it is of particular interest to define any possible
aetiological factor and thus, if possible, prevent the develop-
ment of the disease. Recognition of patients with risk of PLC
may lead to earlier diagnosis and better prognosis. There is
overwhelming evidence that chronic hepatitis B virus (HBV)
infection may result in development of HCC and it appears
to be responsible for at least 80% of cases worldwide
(Beasley, 1988). In low-incidence areas, however, the
aetiological role of HBV infection has been questioned (Seeff
et al., 1987; Zaman et al., 1985; Kaczynski et al., 1991) and,
instead, many other aetiological factors have been suggested
(Anthony, 1987; Dusheiko, 1987; Yu et al., 1991). Many
reports on this subject, however, have similar disadvantages
as reports on the incidence of PLC.
The primary aim of the present study was to state the
incidence of PLC in a low-endemicity area, and the relative
proportions of various subtypes. In order to avoid the interp-
retation difficulties mentioned above the study was limited to
a well-defined population, including all known cases with
PLC, from a defined time period when the autopsy frequency
was high. The secondary aim was to identify probable
aetiological factors in the various PLC subtypes.
Materials and methods
This retrospective study was conducted in Gothenburg,
Sweden, an industrial town with a population varying
between 395 000 and 465 000 during the study period of
1958-79. During these 22 years (according to specially
ordered information from Statistics Sweden) 67% of all
deceased inhabitants in this area underwent either clinical or
forensic autopsy. Since then autopsy frequency has decreased
to about 30%.
The study included all cases of cancer diagnosed after 1
January 1958, the date when the Swedish Cancer Registry
started its activity, until 31 December 1979. The material of
this Registry is based on compulsory reports from physicians
working in hospital as well as pathologists and cytologists
and will be appropriate for study of primary liver cancer
(Kaczynski and Wallerstedt, 1988). The Patient data were
received as a computer-based list from this Registry, and
consisted of cases, coded in accordance with the code given
by WHO (WHO/HS/-CANC/24. 1 Code for Anatomical
Location) and ICD7 as 155.0 i.e. primary liver cancer, and
156, i.e. liver cancer uncertain whether primary or not. The
list comprised all patients with domicile code for Gothenburg
even if the cancer had been diagnosed in some other part of
Sweden. From this list it was possible to identify every
patient by his or her name and unique identification number.
Patients records were searched for and scrutinised. In order
to identify any additional possible unlisted cases a manual
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search of biopsy records, autopsy records and diagnosis
registers from the main hospitals in Gothenburg was per-
formed by one of the authors (JK).
The computer-based Gothenburg list contained 710 cases
registered as primary liver cancer during the study period.
One of the patients turned out to have his official place of
residence outside this city. On the other hand, the manual
search of various registers and records revealed two
unregistered cases of liver malignancy (Kaczynski and
Wallerstedt, 1988). The patients were all Caucasians and
almost all were born in Sweden and thus constituted racially
a homogeneous population. Of these 711 cases 663 (93%)
were diagnosed histopathologically (579 coded as 155.0 and
82 coded as 156). Tissue specimens were available for
examination in 649 (98%) of these 663 cases. The specimens
had been obtained by biopsy ante mortem (needle, wedge
biopsy or tissue blocks of resected tumours) or at autopsy.
Slides from the formalin-fixed, paraffin-embedded tissue spec-
imens were prepared and stained with haematoxylin and
eosin. All the microscope slides were reviewed by two of us
(GH and JK) and studied with regard to the accuracy of the
diagnosis and the histology of the available liver tissue. PLC
was classified according to Anthony (1987) and Wight (1982),
and diagnosis of fibrolamellar carcinoma was based on the
predefined histological criteria of Craig et al. (1980) and
Berman et al. (1980). Only bile-duct carcinomas arising
within the liver were considered as CCC (Wight, 1982).
Age-standardised incidence rate was calculated using
'world population' as a standard (Waterhouse et al., 1982).
More than 90% of the cases had been autopsied. The
autopsy records as well as the case files were scrutinised to
obtain information about possible aetiological factors in
various types of PLC. Information about alcohol habits and
a possible chronic alcoholism was found in 49% of the files.
Information about smoking habits was given in 41% of the
cases.
Standard statistical methods were employed using group
comparison t-test for comparison of two mean values and
z-test for comparison of two proportions.
Results
Review of the microscope slides in 649 cases registered with a
histopathological diagnosis of PLC revealed 590 patients
with this malignancy (Table I). Given the population figures
for each year during the study period, it corresponds to an
average annual incidence of 6.2 PLC cases per 100 000
inhabitants. If the 62 cases with no material to review were
confirmed as PLC, the average annual incidence would inc-
rease to 6.8 cases per 100 000 inhabitants.
In six of the other 59 patients it was not possible to state if
the malignancy was a primary or secondary liver cancer. A
malignancy other than PLC was found in 36 cases, the most
common misregistration being secondary malignancy (n =
20), usually metastases from gastrointestinal tract. Other
malignancies were cancer of extrahepatic biliary passages
(n = 10), gall bladder (n = 4) and lymphoma (n = 2). In the
remaining 17 cases an unspecified malignancy (n= 5), lack of
malignancy (n = 8) or an undeterminable histology due to
autolysis (n = 4) was found.
HCC constituted the majority (90%) of all PLC cases with
CCC as next common (8%) subtype. Thus, the average
relative frequency of HCC expressed as number of cases per
100 000--population per year was 5.6 and would increase to
6.2 if the 62 cases with no material to review were confirmed
as HCC. The age-standardised annual incidence rate of HCC
was 2.3 for the period 1958-62 and 3.6 cases per 100 000
inhabitants for the period 1975-79. Mixed hepatocellular
and cholangiocellular carcinoma and other subtypes were
rare. The patients with HCC and CCC were usually old
(Table I), with no significant difference in mean age between
those two groups. Patients younger than 55 years constituted
7% (n = 36) of all HCC cases and 8% (n
= 4) of all CCC
cases. The corresponding figures for patients younger than 60
years were 15% (n = 79) and 17% (n = 8) and for patients
younger than 65 years 27% (n = 143) and 23% (n = 11) of
the HCC and CCC cases respectively. In 92% of the HCC
cases and in 98% of the CCC cases an autopsy had been
performed.
Cirrhosis of the liver could be established in 72% of cases
with HCC and in 30% of cases with CCC, when non-
neoplastic liver tissue was available for examination (n = 476
and n = 40 respectively) (Table II). The proportion of HCC
cases with cirrhosis was significantly higher in men than in
women (76% and 63% respectively, P<0.01). The corres-
ponding figures for CCC (40% and 24% respectively) did not
differ significantly. Cirrhosis was known or at least clinically
suspected only in the minority of patients before the diag-
nosis of the tumour (29% and 33% in patients with HCC
and CCC respectively). The aetiology of cirrhosis in both
HCC and CCC patients was unknown in about 60% of
cases. In the remaining cases with HCC and cirrhosis the
predominant aetiological factor was alcoholism (Table III).
Other possible aetiological factors in HCC and CCC
patients are listed in Table II. We defined the disorder of
cholelithiasis as a finding of gallstones in gall bladder and/or
in bile ducts at autopsy (n = 127 and n = 22) or cholecystec-
tomy before diagnosis of the tumour (n = 66 and n = 7 in
cases with HCC and CCC respectively).
There were 15 patients (11 men) with HCC which had
been treated with inorganic arsenic because of syphilis. Cirr-
hosis of the liver could be established in all cases where
non-neoplastic liver tissue was available for examination
(n = 12), and there was a strong clinical suspicion and/or
typical macroscopic appearance of cirrhosis at autopsy in an
additional two cases. Two patients had been treated with
anabolic steroids because of osteoporosis.




Diagnosis n (%) MIF x (range)
HCC (excluding FLC) 530 (90) 2/1 70 (11 -96)
FLC 2 (< 1) 0/2 34 (22-46)
HCCC 5 (1) 4/1 71 (64-82)
CCC 48 (8) 1/2 72 (41-92)
Angiosarcoma 1 (<1) 0/1 52
Hepatoblastoma 3 (<1) 2/1 1 (0- 1)
Infantile haemangio- 1 (<1) 1/0 9
endothelioma
HCC, hepatocellular cancer; FLC, fibrolamellar cancer; HCCC,
mixed hepatocellular and cholangiocellular cancer; CCC, cholangiocel-
lular cancer.
Table II Proportion (%) ofvarious possible aetiological factors in 530
cases with hepatocellular carcinoma (HCC) and 48 cases with cholan-
giocellular carcinoma (CCC) in Gothenburg 1958-79
Aetiological HCC
factor (excluding FLC) CCC P-value
Cirrhosis 72 30 <0.001
Alcohol 21 6 <0.05
Cholelitiasisa 36 60 <0.01
Parity 91 67 <0.01
Diabetes 16 9 NS
Transfusionb 6 4 NS
Other tumoursc 6 5 NS
Arsenic 3 0 NS
PCTd 1 0 NS
Haemochromatosis 1 0 NS
Thorotrast 1 0 NS
Anabolic steroids <1 0 NS
Tyrosinaemia <1 0 NS
Colitis ulcerosa <1 0 NS
asee text. bMore than 6 months before diagnosis.cOther malignant
tumourstreatedsuccessfullybeforediagnosisoflivercancer. dHistoryof
alcohol abuse in 50%. FLC, fibrolamellar carcinoma; PCT, porphyria
cutanea tarda; NS, not significant.I Incidence and aetiology of liver tumours
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Table III Plausible aetiology ofcirrhosis in 341 cases with hepatocel-
lular carcinoma in Gothenburg 1958-79
Sex
Aetiology n (%) MIF
Alcohol 99 (29) 19/1
Hepatitisa 13 (4) 2/1
Arsenicb 12 (4) 5/1
PCT 5 (1) 3/2
Thorotrastd 3 (1) 2/1
Haemochromatosis 3 (1) 3/0
PBC 2 (1) 0/2
CAH 2 (1) 0/2
Tyrosinaemia 1 (<1) 1/0
Cirrhosis cardiacae 1 (<1) 1/0
Unknowna 208 (61) 2/1
aSee text. bHistory ofalcohol abuse (n = 3), alcohol and PCT (n = 1),
historyofhepatitis (n = 2). cHistory ofalcohol abuse(n = 2). dHistoryof
alcohol abuse (n = 1), PCT (n = 1). PCT, porphyria cutanea tarda;
PBC, primary biliary cirrhosis; CAH, chronic active hepatitis.
Two cases of fibrolamellar carcinoma were found and thus
constituted less than 1% of all HCC cases. Neither of these
two patients had cirrhosis or any other liver disease.
There was one patient each with angiosarcoma and infan-
tile haemangioendothelioma. The first one had undergone a
radiographic examination by using the contrast dye Thorot-
rast 33 years before admission. Histological examination
revealed angiosarcoma in a non-cirrhotic liver and deposition
of Thorotrast in tumour tissue and lymph nodes. The patient
with infantile haemangioendothelioma reported as PLC died
post-operatively a couple of weeks after onset of symptoms.
Discussion
The design of our study was aimed at minimising many
sources of error that afflict most reports on incidence and
aetiology of PLC and relative proportions of different his-
tological types. Many reports derive from referral centres
without a defined population, and thus the selection proce-
dure may influence the results. In dealing with epidemi-
ological data it is also important to include all known cases
and that the diagnosis is correct. As is seen in the present
study, re-evaluation of preserved biopsy specimens revealed
diagnosis other than the reported PLC in 9%.
Our report concerns a specified region with a well-defined
population, and during the study period all known cases with
PLC were taken into consideration (Kaczynski and Wallers-
tedt, 1988). As a result of a high autopsy frequency during
the study period, histologically proven diagnosis in the vast
majority of cases and preservation of biopsy material for
re-evaluation we had a unique opportunity to present reliable
figures about the incidence and proportion of various types
of PLC in a low-endemic area.
Incidence ofHCC
According to Anthony (1987) the relative frequency of HCC
in the world expressed as number of cases per 100 000
population per year is 20-150 in high-incidence areas, 5-20
in intermediate- and less than 5 in low-incidence areas, e.g.
north Europe. Our presented incidence rates confirm that
Gothenburg is a low-incidence area of HCC.
Relative proportion ofPLC subtypes
The relative proportions of rare PLC subtypes in our study
from a low-incidence area are similar to the results from a
large survey from Japan (Liver Cancer Study Group of
Japan, 1990), although in that study only 37% of all reported
cases with PLC were histologically proven and analysed. The
ratio HCC/CCC in that study was 17:1 compared with 11:1
in our study.
The main disadvantage of a retrospective, compared with a
prospective study, is systematic bias. On the other hand,
since the diagnosis of both HCC and CCC was known or
suspected ante mortem in only about 30% of cases in our
study, a prospective study would concern at most a third of
the patients. Furthermore, as a result of a very low incidence
(of CCC especially) in our area, such a study would be
difficult to carry out. Since our report considers all known
cases with PLC during the study period it was possible to
compare the proportion of various aetiological factors in
HCC and CCC cases.
HCC
Our findings of a high frequency of liver cirrhosis in cases
with HCC and, compared with populations with a high PLC
incidence, a higher age of patients and a less striking male
preponderance are in accordance with other reports (Lef-
kowitch, 1981; Anthony, 1987; Colombo, 1992). In patients
with HCC and underlying liver cirrhosis of known aetiology,
alcohol was by far the most important factor (Table III).
In some cases there was a history ofhepatitis more than 10
years before diagnosis of HCC (Table III), but lack of pre-
served sera made it impossible to state the role of a previous
viral hepatitis. However, as reported before (Kaczynski et al.,
1991), HBV seems to be of minor importance in the aetiology
of HCC in our study area. The role of hepatitis C virus
(HCV) in the aetiology of HCC (Simonetti et al., 1991;
Resnick and Koff, 1993) in our area may, however, only be
answered in a prospective study.
Since liver cirrhosis is associated with risk of HCC it has
been suggested that those patients should be followed
regularly and screened by ultrasonography and undergo
measurement of serum alpha fetoprotein (Oka et al., 1994).
As shown in our study, however, it must be stated that an
underlying liver cirrhosis was diagnosed only in the minority
of patients with HCC before development of the tumour.
History of transfusion has been correlated with risk of
HCC in some studies, in at least some cases probably due to
HBV and/or HCV infection (Fukuda et al., 1989). We were
not able to confirm this suggestion since transfusions were
reported unusual in both HCC and CCC patients in our
study. Diabetes has also been reported to be correlated with
HCC (Lawson et al., 1986; Yu et al., 1991). In our study
there was no significant difference in frequency of diabetes
between HCC and CCC, and the prevalence of diabetes was
as expected in this age group (Schersten, 1992). Parity as a
risk factor is controversial (Hsing et al., 1992; Lambe et al.,
1993). We found a significant higher history ofparity among
women with HCC than among women with CCC. There was
no significant difference regarding number of births between
those two groups, a factor which has also been suggested as a
risk factor for development of HCC (Hsing et al., 1992).
Chronic exposure to inorganic arsenic has been implicated
in the pathogenesis of angiosarcoma in German vineyard
workers (Popper et al., 1978) and after treatment with
Fowler's solution (Lander et al., 1975). Since inorganic
arsenic may predispose for liver fibrosis (Anthony, 1987) and
cirrhosis (Lander et al., 1975; Popper et al., 1978) it may also
increase the risk of HCC. Most of our patients with HCC
who had been treated with arsenic had liver cirrhosis.
Development of HCC after treatment of syphilis with arsenic
has not been reported previously.
Thus our data give some support to the theory that
alcohol may be one of the main factors for the development
of HCC in the West (N0rredam, 1979; Tamburro and Lee,
1981; Hardell et al., 1984; Bassendine, 1986; Yu et al., 1991).
CcC
The next commonest PLC type, CCC, is reported to be a
disease of older individuals, to affect both sexes equally
(Okuda et al., 1977; Wight, 1982; Anthony, 1987) and to
account for between 5% and 30% of all cases of PLC
(Okuda et al., 1977; N0rredam, 1979; Bassendine, 1986;Incidence and aetiology of liver tumours 0&,6
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Johnson, 1987; Altaee et al., 1991). In our study, this type
was twice as common in women than in men (Table I), and
although the patients were mostly old there was no
significant age difference between CCC and HCC patients.
Contrary to HCC, there seems to be no association
between cirrhosis and CCC. Cirrhosis in cases with CCC is
sometimes believed to be a consequence of the tumour
(Wight, 1982) and is reported in between 0% and 15% of all
cases with CCC (Okuda et al., 1977; Johnson, 1987; Altaee et
al., 1991). Almost one-third of the cases with CCC in our
study had liver cirrhosis and though the frequency was
significantly lower than in cases with HCC, cirrhosis may not
be excluded as a contributing factor in the aetiology of CCC.
There was a remarkable correlation between cholelithiasis
and CCC in our study. Cholecystectomy has been reported
to decrease the risk of extrahepatic bile duct cancer and
increase the risk of PLC, though only during the first year
after operation (Ekbom et al., 1993). The role of gallstones in
aetiology of CCC has been controversial. Although a correla-
tion between intrahepatic gallstones and extrahepatic bile
duct cancer has been found in Thailand (Chen et al., 1989), a
finding of gallstones is reported in only 3-18% in most
studies of CCC (Altaee et al., 1991; Okuda et al., 1977). The
incidence of gallstones is reported to increase with age and
may be as high as 30% in patients older than 70 years
(Karran et al., 1985). Cirrhosis has also been reported to
increase the risk of gallstones (Bouchier, 1969). The propor-
tion of liver cirrhosis in patients with HCC was higher than
in patients with CCC in our study, and there was no
significant age difference between those two groups. Despite
that, the proportion of cholelithiasis in patients with CCC
was significantly higher than in patients with HCC (Table II).
Thus, cholelithiasis may be an important aetiological factor
in CCC in a low-incidence area of PLC.
We conclude that (a) HCC and CCC in our study popula-
tion are diseases of older people with no significant difference
in age between them; (b) alcohol may be one of the main
factors in the development of HCC in the West; (c) liver
cirrhosis is clearly correlated with the risk of HCC but is in
majority of the cases unknown before diagnosis of the
tumour; (d) cholelithiasis may be one of the main aetiological
factors in development of CCC in a low-incidence area.
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